查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786987

週邊動脈疾病市場，規模，佔有率，趨勢，產業分析報告:治療類別，各流通管道，各終端用戶，各地區- 市場預測，2025年～2034年

Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，週邊動脈疾病 (PAD) 市場規模預計到 2034 年將達到 105.3 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

週邊動脈疾病 (PAD) 市場專注於週邊動脈粥狀硬化阻塞的診斷、治療和管理，主要影響下肢。這種疾病會導致血流減少，進而引起疼痛、組織損傷，嚴重時甚至需要截肢。糖尿病、高血壓、吸煙和肥胖等風險因素的日益流行，正在擴大目標人群，並推動對有效 PAD 治療的需求。血管影像和早期診斷工具的進步正在提高檢出率，而微創治療的轉變使得血管內治療優於傳統手術。藥物洗脫支架、球囊血管成形術和動脈粥狀硬化斑塊切除系統等技術進步正在改善患者的預後和手術效率。針對疾病嚴重程度和患者合併症的聯合療法和個人化治療方法的發展進一步推動了市場的發展。

數位健康平台與血管護理的整合實現了遠端監控、治療依從性和數據驅動的干預。對研究和臨床試驗的大力投資持續推動技術創新，尤其是在抗再狹窄器械和生物可吸收植入物方面。醫療保健提供者、醫療技術公司和研究機構之間的策略聯盟正在促進先進週邊動脈疾病 (PAD) 解決方案的商業化。此外，宣傳活動和篩檢計劃鼓勵早期幹預並擴大潛在市場。對基於價值的護理和以患者為中心的護理模式的日益重視，正在推動具有成本效益、以結果為導向的外周動脈疾病 (PAD) 治療的重要性。市場競爭和技術創新仍然激烈，為致力於解決週邊血管疾病管理領域未滿足需求的利害關係人提供了龐大的商機。

週邊動脈疾病市場報告重點

按治療類型劃分，預計到2024年，器械細分市場的收入將占到總收入的約62%，因為支架、血管成形術球囊和微創動脈粥樣硬化切除器械的日益普及將推動市場需求的強勁增長。

按分銷管道劃分，預計到2024年，醫院藥房細分市場的收入將占到最大佔有率，因為大量患者湧入醫院進行複雜的外周動脈疾病 (PAD) 幹預，例如血管成形術和搭橋手術，這將進一步推動醫院藥房佔主導地位。

預計亞太地區將在2025年至2034年期間經歷顯著增長，這得益於醫療保健體系的快速擴張、可支配收入的增加以及健康意識的增強，這些因素都將促進外周動脈疾病 (PAD) 篩檢和診斷的改善。率。

由於糖尿病、肥胖和吸菸等心血管危險因子的普遍性，預計北美週邊動脈疾病市場將在 2024 年佔最大的收入佔有率。

主要的全球公司包括 Amedisys, Inc.、B. Braun SE、Baxter、BD、CareCentrix, Inc.、Coram LLC.、Fresenius Kabi AG、ICU Medical, Inc.、JMS Co. Ltd.、Moog Inc.、Option Care Health, Inc.、PharMerica Corporation 和 Terumo Corporation。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球週邊動脈疾病市場洞察

  • 市場概況
  • 週邊動脈疾病市場動態
    • 驅動因素與機遇
      • 糖尿病和高血壓盛行率上升
      • 全球人口老化
    • 限制與挑戰
      • 治療費用高。
  • PESTEL分析
  • 週邊動脈疾病的市場趨勢
  • 價值鏈分析

第5章 全球週邊動脈疾病市場:治療類別

  • 主要調查結果
  • 簡介
  • 設備
  • 藥物類型

第6章 全球週邊動脈疾病市場:各流通管道

  • 主要調查結果
  • 簡介
  • 醫院藥局
  • 零售藥局
  • 其他

第7章 全球週邊動脈疾病市場:各終端用戶

  • 主要調查結果
  • 簡介
  • 醫院
  • 專門診所
  • 門診病人手術中心

第8章 全球週邊動脈疾病市場:地區

  • 主要調查結果
  • 簡介
    • 週邊動脈疾病市場評估:地區，2020年～2034年
  • 北美
    • 北美:治療類別，2020年～2034年
    • 北美:各流通管道，2020年～2034年
    • 北美:各終端用戶，2020年～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:治療類別，2020年～2034年
    • 歐洲:各流通管道，2020年～2034年
    • 歐洲:各終端用戶，2020年～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:治療類別，2020年～2034年
    • 亞太地區:各流通管道，2020年～2034年
    • 亞太地區:各終端用戶，2020年～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:治療類別，2020年～2034年
    • 中東·非洲:各流通管道，2020年～2034年
    • 中東·非洲:各終端用戶，2020年～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:治療類別，2020年～2034年
    • 南美:各流通管道，2020年～2034年
    • 南美:各終端用戶，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Abbott
  • AngioDynamics
  • B. Braun SE
  • Bayer AG
  • BD
  • Biotronik
  • Boston Scientific Corporation
  • Cardinal Health
  • Endologix LLC
  • iVascular
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Medtronic
  • Terumo Corporation
Product Code: PM6022

The peripheral artery disease (PAD) market size is expected to reach USD 10.53 billion by 2034, according to a new study by Polaris Market Research. The report "Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034," gives a detailed insight into current market dynamics and provides analysis on future market growth.

The peripheral artery disease (PAD) market focuses on the diagnosis, treatment, and management of atherosclerotic blockages in the peripheral arteries, primarily affecting the lower extremities. This condition leads to reduced blood flow, causing pain, tissue damage, and in severe cases, limb amputation. The increasing prevalence of risk factors such as diabetes, hypertension, smoking, and obesity is expanding the target population and fueling demand for effective PAD therapies. Advancements in vascular imaging and early diagnostic tools are improving detection rates, while the shift toward minimally invasive procedures is driving preference for endovascular treatments over traditional surgery. Technological progress in drug-eluting stents, balloon angioplasty, and atherectomy systems is enhancing patient outcomes and procedural efficiency. Market growth is further supported by the development of combination therapies and personalized treatment approaches tailored to disease severity and patient comorbidities.

The integration of digital health platforms into vascular care is enabling remote monitoring, treatment adherence, and data-driven interventions. Strong investments in research and clinical trials continue to shape innovation, particularly in anti-restenosis devices and bioresorbable implants. Strategic collaborations among healthcare providers, medtech firms, and research institutions are fostering the commercialization of advanced PAD solutions. In addition, increasing awareness campaigns and screening initiatives are encouraging earlier intervention, thus expanding the addressable market. Growing emphasis on value-based care and patient-centric treatment models is reinforcing the importance of cost-effective and outcome-driven PAD therapies. The market remains competitive and innovation-driven, presenting substantial opportunities for stakeholders committed to addressing unmet needs in peripheral vascular disease management.

Peripheral Artery Disease Market Report Highlights

By treatment type, the device segment accounted for ~62% of the revenue share in 2024, due to the wider adoption of stents, angioplasty balloons, and atherectomy devices for minimally invasive procedures is contributing to strong demand in the device segment.

Based on distribution channel, the hospital pharmacy segment accounted for the largest revenue share in 2024 due to the high patient inflow for complex PAD interventions, such as angioplasty or bypass surgeries, contributes to the dominance of hospital pharmacies.

Asia Pacific is expected to grow significantly from 2025 to 2034 due to rapidly expanding healthcare systems, rising disposable income, and growing health awareness are contributing to improved PAD screening and diagnosis rates.

The North America peripheral artery disease market accounted for the largest revenue share in 2024 due to the high prevalence of cardiovascular risk factors, such as diabetes, obesity, and smoking, has increased the burden of peripheral artery disease across the region.

A few global key players include Amedisys, Inc.; B. Braun SE; Baxter; BD; CareCentrix, Inc.; Coram LLC.; Fresenius Kabi AG; ICU Medical, Inc.; JMS Co. Ltd.; Moog Inc.; Option Care Health, Inc.; PharMerica Corporation; and Terumo Corporation.

Polaris Market Research has segmented the peripheral artery disease market report on the basis of treatment type, distribution channel, end user, and region:

By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)

Device

Balloon Catheters

Plaque Modification Devices

Stents

Atherectomy Devices

Guidewires and Sheaths

Other Devices

Drug Type

Lipid-lowering Drugs

Antiplatelet Drugs

Thrombolytic Agents

Triple-H Therapy

Other Drugs

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospital Pharmacy

Retail Pharmacy

Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospital

Specialty Clinics

Ambulatory Surgical Centers

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Peripheral Artery Disease Market Insights

  • 4.1. Peripheral Artery Disease Market - Market Snapshot
  • 4.2. Peripheral Artery Disease Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Diabetes and Hypertension
      • 4.2.1.2. Aging Global Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High treatment costs.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Peripheral Artery Disease Market Trends
  • 4.6. Value Chain Analysis

5. Global Peripheral Artery Disease Market, by Treatment Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • 5.3. Device
    • 5.3.1. Global Peripheral Artery Disease Market, by Device, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Balloon Catheters
      • 5.3.2.1. Global Peripheral Artery Disease Market, by Balloon Catheters, 2020-2034 (USD Billion)
    • 5.3.3. Plaque Modification Devices
      • 5.3.3.1. Global Peripheral Artery Disease Market, by Plaque Modification Devices, by Region, 2020-2034 (USD Billion)
    • 5.3.4. Stents
      • 5.3.4.1. Global Peripheral Artery Disease Market, by Stents, 2020-2034 (USD Billion)
    • 5.3.5. Atherectomy Devices
      • 5.3.5.1. Global Peripheral Artery Disease Market, by Atherectomy Devices, by Region, 2020-2034 (USD Billion)
    • 5.3.6. Guidewires and Sheaths
      • 5.3.6.1. Global Peripheral Artery Disease Market, by Guidewires and Sheaths, 2020-2034 (USD Billion)
    • 5.3.7. Other Devices
      • 5.3.7.1. Global Peripheral Artery Disease Market, by Other Devices, by Region, 2020-2034 (USD Billion)
  • 5.4. Drug Type
    • 5.4.1. Global Peripheral Artery Disease Market, by Drug Type, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Lipid-lowering Drugs
      • 5.4.2.1. Global Peripheral Artery Disease Market, by Lipid-lowering Drugs, 2020-2034 (USD Billion)
    • 5.4.3. Antiplatelet Drugs
      • 5.4.3.1. Global Peripheral Artery Disease Market, by Antiplatelet Drugs, by Region, 2020-2034 (USD Billion)
    • 5.4.4. Thrombolytic Agents
      • 5.4.4.1. Global Peripheral Artery Disease Market, by Thrombolytic Agents, 2020-2034 (USD Billion)
    • 5.4.5. Triple-H Therapy
      • 5.4.5.1. Global Peripheral Artery Disease Market, by Triple-H Therapy, by Region, 2020-2034 (USD Billion)
    • 5.4.6. Other Drugs
      • 5.4.6.1. Global Peripheral Artery Disease Market, by Other Drugs, 2020-2034 (USD Billion)

6. Global Peripheral Artery Disease Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 6.3. Hospital Pharmacy
    • 6.3.1. Global Peripheral Artery Disease Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
  • 6.4. Retail Pharmacy
    • 6.4.1. Global Peripheral Artery Disease Market, by Retail Pharmacy, by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Peripheral Artery Disease Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Peripheral Artery Disease Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • 7.3. Hospital
    • 7.3.1. Global Peripheral Artery Disease Market, by Hospital, by Region, 2020-2034 (USD Billion)
  • 7.4. Specialty Clinics
    • 7.4.1. Global Peripheral Artery Disease Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
  • 7.5. Ambulatory Surgical Centers
    • 7.5.1. Global Peripheral Artery Disease Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)

8. Global Peripheral Artery Disease Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Peripheral Artery Disease Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Peripheral Artery Disease Market - North America
    • 8.3.1. North America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.3. North America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.3.4. Peripheral Artery Disease Market - U.S.
      • 8.3.4.1. U.S.: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.3.5. Peripheral Artery Disease Market - Canada
      • 8.3.5.1. Canada: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • 8.4. Peripheral Artery Disease Market - Europe
    • 8.4.1. Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.4. Peripheral Artery Disease Market - UK
      • 8.4.4.1. UK: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.5. Peripheral Artery Disease Market - France
      • 8.4.5.1. France: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.6. Peripheral Artery Disease Market - Germany
      • 8.4.6.1. Germany: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.7. Peripheral Artery Disease Market - Italy
      • 8.4.7.1. Italy: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.8. Peripheral Artery Disease Market - Spain
      • 8.4.8.1. Spain: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.9. Peripheral Artery Disease Market - Netherlands
      • 8.4.9.1. Netherlands: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.10. Peripheral Artery Disease Market - Russia
      • 8.4.10.1. Russia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.4.11. Peripheral Artery Disease Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • 8.5. Peripheral Artery Disease Market - Asia Pacific
    • 8.5.1. Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.4. Peripheral Artery Disease Market - China
      • 8.5.4.1. China: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.5. Peripheral Artery Disease Market - India
      • 8.5.5.1. India: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.6. Peripheral Artery Disease Market - Malaysia
      • 8.5.6.1. Malaysia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.7. Peripheral Artery Disease Market - Japan
      • 8.5.7.1. Japan: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.8. Peripheral Artery Disease Market - Indonesia
      • 8.5.8.1. Indonesia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.9. Peripheral Artery Disease Market - South Korea
      • 8.5.9.1. South Korea: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.10. Peripheral Artery Disease Market - Australia
      • 8.5.10.1. Australia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.5.11. Peripheral Artery Disease Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • 8.6. Peripheral Artery Disease Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.6.4. Peripheral Artery Disease Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.6.5. Peripheral Artery Disease Market - UAE
      • 8.6.5.1. UAE: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.6.6. Peripheral Artery Disease Market - Israel
      • 8.6.6.1. Israel: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.6.7. Peripheral Artery Disease Market - South Africa
      • 8.6.7.1. South Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.6.8. Peripheral Artery Disease Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • 8.7. Peripheral Artery Disease Market - Latin America
    • 8.7.1. Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.7.4. Peripheral Artery Disease Market - Mexico
      • 8.7.4.1. Mexico: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.7.5. Peripheral Artery Disease Market - Brazil
      • 8.7.5.1. Brazil: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.7.6. Peripheral Artery Disease Market - Argentina
      • 8.7.6.1. Argentina: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
    • 8.7.7. Peripheral Artery Disease Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AngioDynamics
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. B. Braun SE
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bayer AG
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. BD
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Biotronik
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Boston Scientific Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Cardinal Health
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Endologix LLC
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. iVascular
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Johnson & Johnson
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Koninklijke Philips N.V.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Medtronic
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Terumo Corporation
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development

List of Tables:

  • Table 1 Global Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 2 Global Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 3 Global Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 4 North America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 5 North America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 6 North America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 7 U.S.: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 9 U.S.: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 10 Canada: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 12 Canada: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 15 Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 16 UK: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 17 UK: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 18 UK: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 19 France: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 20 France: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 21 France: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 22 Germany: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 24 Germany: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 25 Italy: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 27 Italy: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 28 Spain: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 30 Spain: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 34 Russia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 36 Russia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 43 China: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 44 China: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 45 China: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 46 India: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 47 India: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 48 India: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 52 Japan: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 54 Japan: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 58 South Korea: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 60 South Korea: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Australia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 63 Australia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 73 UAE: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 75 UAE: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 76 Israel: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 78 Israel: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 79 South Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 81 South Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 87 Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 88 Mexico: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 90 Mexico: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 91 Brazil: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 93 Brazil: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 94 Argentina: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 96 Argentina: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Peripheral Artery Disease Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Treatment Type
  • Figure 7. Global Peripheral Artery Disease Market, by Treatment Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Peripheral Artery Disease Market, by Distribution Channel, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End User
  • Figure 11. Global Peripheral Artery Disease Market, by End User, 2024 & 2034 (USD Billion)